| Product NDC: | 59883-175 |
| Proprietary Name: | Chlorhexidine Gluconate |
| Non Proprietary Name: | Chlorhexidine Gluconate |
| Active Ingredient(s): | 56.76 mL/mL & nbsp; Chlorhexidine Gluconate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 59883-175 |
| Labeler Name: | Zila Therapeutics |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA077789 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20090618 |
| Package NDC: | 59883-175-16 |
| Package Description: | 473 mL in 1 BOTTLE, PLASTIC (59883-175-16) |
| NDC Code | 59883-175-16 |
| Proprietary Name | Chlorhexidine Gluconate |
| Package Description | 473 mL in 1 BOTTLE, PLASTIC (59883-175-16) |
| Product NDC | 59883-175 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Chlorhexidine Gluconate |
| Dosage Form Name | SOLUTION |
| Route Name | ORAL |
| Start Marketing Date | 20090618 |
| Marketing Category Name | ANDA |
| Labeler Name | Zila Therapeutics |
| Substance Name | CHLORHEXIDINE GLUCONATE |
| Strength Number | 56.76 |
| Strength Unit | mL/mL |
| Pharmaceutical Classes | Decreased Cell Wall Integrity [PE] |